Quitting Jobs, Wrong Diagnoses, and What Happens to Your Skin
Quick Summary
This episode covers three things getting a lot of attention right now: new research on menopause symptoms pushing women out of the workforce, a Cambridge University study on how often women's autoimmune symptoms get dismissed as psychological, and a dermatologist-backed breakdown of what actually works for skin changes after menopause.
Quitting Jobs, Wrong Diagnoses, and What Happens to Your Skin
Key Takeaways
- ✦Research suggests menopause-related psychological symptoms — not just physical ones — are a significant driver of women leaving paid work, with mood, anxiety, and cognitive changes being underreported reasons.
- ✦A Cambridge University study found women with autoimmune conditions are up to 74% more likely than men to be told their symptoms are psychological, and they wait longer for diagnosis and treatment.
- ✦Many autoimmune conditions — including those that cause fatigue, joint pain, and brain fog — can emerge or worsen during perimenopause, making the overlap with menopause symptoms especially hard to untangle.
- ✦On skin: a board-certified dermatologist consulted on the unPAUSED podcast says the evidence does not support endocrine-disruption fears about chemical sunscreens at normal use levels — the bigger skin enemy after menopause is unprotected sun exposure.
- ✦Topical estrogen and retinoids are among the best-studied options for menopause-related skin thinning; laser and cosmetic treatments can help but work best layered on top of a solid daily routine, not instead of one.
Sources & References
Episode Script
Thanks Toni. We've got a good one today — let's get into it.
There's a study making the rounds this week on menopause and work. The headline is that menopause-related psychological symptoms may be pushing women out of their jobs. And I want to spend a minute on that word: psychological. Because in this context it doesn't mean imaginary. It means mood changes, anxiety, difficulty concentrating, memory gaps — the mental and emotional side of menopause that tends to get a lot less airtime than hot flashes and night sweats, but is often what quietly dismantles someone's working life.
The research, covered by News-Medical, looks at how these symptoms intersect with job performance and the decision to reduce hours or leave work altogether. And the detail that keeps coming back to me is that it's not always the physical symptoms driving women out. It's the cognitive ones. Brain fog that makes meetings harder. Anxiety that makes deadlines feel insurmountable. Low mood that makes it hard to advocate for yourself with a manager who has no framework for what you're going through.
Here's my actual position on this: we have been drastically undercounting the occupational cost of menopause because we've been tracking the wrong symptoms. When researchers and HR departments think about menopause at work, they tend to picture someone who needs a fan at her desk. They're not picturing a senior project manager who can't pull up a word she's used a thousand times and starts declining to speak in meetings because of it. The psychological burden is real, it's measurable, and it's costing women — and the organizations they work for — far more than anyone has properly accounted for.
There's also a practical gap here. A woman who's struggling with hot flashes might feel comfortable telling her GP. A woman who feels like her brain is slipping, or like she cries in the car on the way home three days a week, may be much less likely to name that as a menopause symptom. She may not even know it is one. And if she doesn't name it, her doctor can't address it, and she's left managing it alone — usually by scaling back or stepping away from work entirely.
That's a loss on every level. And the fact that we're just now building research infrastructure to document it tells you something about how long these experiences have gone untracked.
Which connects, in a painful way, to the Cambridge University study that came out earlier this month. Because if you are a woman in midlife whose symptoms are getting dismissed — whether that's menopause symptoms or something else entirely — the Cambridge data tells us the odds were already working against you before you walked through the door.
The study found that women with autoimmune conditions are up to 74% more likely than men to be told their symptoms are psychological or psychosomatic. They also wait longer to get a diagnosis and longer to get treatment. This was published in a peer-reviewed context and covered by The Guardian, and the sample it draws on is large enough to take seriously — we're talking about conditions that affect roughly one in ten people globally.
Now, why does this matter specifically for a menopause audience? Because autoimmune conditions — things like lupus, rheumatoid arthritis, Hashimoto's thyroiditis, multiple sclerosis — frequently emerge or flare during perimenopause. The hormonal shifts of that transition appear to affect immune regulation, so a woman who had subclinical or mild autoimmune activity for years may start having significant symptoms right around 44, 47, 50. And her symptoms — fatigue, joint pain, brain fog, mood changes — overlap almost completely with menopause symptoms.
So she walks into a doctor's office. She's in her late forties. She's tired, her joints ache, she can't think straight. The doctor may assume menopause. Or — and this is what the Cambridge data is documenting — the doctor may hear all of that and conclude she's anxious or depressed and send her home with a referral to therapy. Neither of those responses investigates whether she has an autoimmune condition. And she may spend years — the study suggests the wait for diagnosis and treatment is substantially longer for women — going back and forth before someone runs the right panel.
The medical-system problem here isn't that any individual doctor is malicious. It's that the training, the default assumptions, and the time pressure of a standard appointment all compound against women. A five-minute slot doesn't give a clinician room to sit with ambiguity. And when the cultural default is still that women are more emotionally reactive, more likely to somatize — to express distress as physical symptoms — that assumption becomes a diagnostic shortcut that gets women hurt.
If you are someone who has been told your symptoms are probably stress, anxiety, or just menopause, and you have not had a full autoimmune workup, it is worth asking for one. Specifically. Not "could this be something else?" but "can we run an ANA panel and thyroid antibodies?" Your doctor may already have a good reason they haven't — but you are entitled to ask the question directly.
Skin. Let's talk about skin.
The unPAUSED podcast with Dr. Mary Claire Haver just dropped an episode with Dr. Erica Kelly — she's a board-certified dermatologist and a Clinical Professor at the University of Texas Medical Branch. And it's a genuinely useful listen because Dr. Kelly goes through a lot of the questions that are filling everyone's feeds right now and gives you actual evidence rather than influencer takes.
The one I want to flag first is the chemical sunscreen debate. If you've been on Instagram in the last two years, you've probably seen someone telling you that chemical sunscreens are disrupting your hormones and you need to switch to mineral immediately. Dr. Kelly's position, based on the current evidence, is that the endocrine-disruption fear is not supported at the levels of exposure you'd get from normal sunscreen use. Some sunscreen ingredients have shown hormonal activity in lab studies — the key word being lab, meaning in a dish, not in a human body at the concentrations you're actually applying. The bigger skin problem after menopause, she says, is UV damage from not wearing sunscreen at all. So if mineral sunscreen works for your skin and your skin tone, great. If you've been avoiding sunscreen entirely because you're scared of chemical filters, that tradeoff is almost certainly going the wrong direction.
On the broader picture of menopause and skin: estrogen does a lot for skin thickness, moisture, and elasticity. When estrogen drops, skin can get thinner, drier, and more prone to sagging. This is not vanity — it's physiology, and it's worth addressing if it's bothering you. The treatments with the strongest evidence behind them include topical retinoids — which help with cell turnover and collagen production — and topical estrogen applied to the face or body, which some dermatologists and menopause specialists prescribe specifically for skin. Laser treatments and things like Botox can help with specific concerns, but Dr. Kelly's framing was essentially: cosmetic procedures work best when they're layered on top of a solid daily routine, not instead of one. If you're not wearing sunscreen and you're not moisturizing and you're not on anything that addresses the underlying hormone-related thinning, lasers are doing a lot of work for a short window.
The sunscreen piece is where I'll push back slightly on the broader wellness conversation — not on Dr. Kelly, but on the trend. The chemical-versus-mineral debate has consumed enormous amounts of attention in menopause spaces, and I think it's partly because it gives people something concrete and controllable to do when the bigger variables feel overwhelming. Switching sunscreens is easy. Dealing with the actual impact of estrogen loss on your skin, which might involve a conversation with a doctor about topical hormones, is harder. Both things matter. The sunscreen matters. But I'd rather see the energy go toward the conversation that actually moves the needle.
Sources curated automatically by the Hot Flasher pipeline.
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.